Recombinant Newcastle Disease Virus

Details for Australian Patent Application No. 2005303912 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Puhler, Florian; Bosslet, Klaus; Beier, Rudolf; Willuda, Hans Jorg

Agent Davies Collison Cave

Pub. Number AU-B-2005303912

PCT Pub. Number WO2006/050984

Priority 04090432.8 12.11.04 EP

Filing date 10 November 2005

Wipo publication date 18 May 2006

Acceptance publication date 17 February 2011

International Classifications

C07K 14/115 (2006.01) Peptides having more than 20 amino acids

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/050984 Priority application(s): WO2006/050984

17 February 2011 Application Accepted

  Published as AU-B-2005303912

16 June 2011 Standard Patent Sealed

7 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005303914-A filter with a fuse, for use in a lamppost

2005303904-Azaindole carboxamides